Prelude Therapeutics Incorporated (PRLD) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Prelude Therapeutics Incorporated, with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -2.24x | -0.76x | -2.12x | -2.48x | -5.31x | -54.93x |
| P/B Ratio | 3.25x | 0.73x | 1.09x | 1.46x | 2.07x | 14.74x |
| P/S Ratio | 18.38x | 13.75x | 0.00x | 0.00x | 0.00x | 0.00x |
| Profitability | ||||||
| Gross Margin | 85.9% | 100.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Margin | -861.3% | -1995.9% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Margin | -819.6% | -1816.8% | 0.0% | 0.0% | 0.0% | 0.0% |
| EBITDA Margin | -847.2% | -1970.6% | 0.0% | 0.0% | 0.0% | 0.0% |
| Liquidity | ||||||
| Current Ratio | 1.99x | 5.30x | 10.79x | 9.42x | 15.37x | 19.41x |
| Quick Ratio | 1.99x | 5.30x | 10.79x | 9.42x | 15.37x | 19.41x |
| Leverage | ||||||
| Debt/Equity | 0.26x | 0.14x | 0.07x | 0.01x | 0.01x | 0.00x |
YoY = year-over-year change. Source: FMP..